REGENXBIO develops gene therapies that use AAV vectors to deliver working genes into cells to treat disease. It last closed at $7.16 on Nov 20, down 0.28% on the day. The next earnings report for RGNX is expected around Thu, Mar 4, 2027. For the quarter ended Sep 2026, RGNX reported EPS of -$0.62 on revenue of $9.2M, with revenue down 69.2% from a year ago. Over its last 8 reports the stock moved an average of 8.4% the session after earnings. Over the last 12 months RGNX insiders bought $949K of stock on the open market and sold $940K, according to SEC Form 4 filings.
AI Auto Pilots
Is RGNX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RGNX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on RGNXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
RGNX · as of the Nov 20 close · updated each morning
Downtrend
The stock is 4% below its 20 day and 5% below its 50 day average. It is 23% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 45). The nearest support is the swing low (Sep 24) at $7.12, and the nearest resistance the swing high (Jun 1) at $7.32.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 7.7%/day
Key levels
$16.1952 week high+126.1%
$9.10100 day average+27.1%
$8.79200 day average+22.8%
$7.5150 day average+4.9%
$7.4320 day average+3.8%
$7.35Pivot R1+2.7%
$7.32Swing high (Jun 1)+2.2%
$7.16Last close
$7.12Swing low (Sep 24)−0.6%
$7.11Pivot−0.7%
$6.91Pivot S1−3.5%
$5.4652 week low−23.7%
Indicators
RSI (14)
44.86
Middle of its range
Neutral
MACD
-0.06
Below its signal line
Bearish
Stochastic
17.9
Near the bottom of its range
Oversold
ADX (14)
12.1
No clear trend
Williams %R
-84.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-64.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−6.0%
Change over 10 sessions
Bearish
ATR (14)
$0.55
Typical daily range, 7.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 21.0%/day
Key levels
$16.1952 week high+126.1%
$9.10100 day average+27.1%
$8.79200 day average+22.8%
$7.5150 day average+4.9%
$7.4320 day average+3.8%
$7.35Pivot R1+2.7%
$7.32Swing high (Jun 1)+2.2%
$7.16Last close
$7.12Swing low (Sep 24)−0.6%
$7.11Pivot−0.7%
$6.91Pivot S1−3.5%
$5.4652 week low−23.7%
Indicators
RSI (14)
42.72
Middle of its range
Neutral
MACD
-0.64
Below its signal line
Bearish
Stochastic
18.1
Near the bottom of its range
Oversold
ADX (14)
12.4
No clear trend
Williams %R
-87.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-76.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−16.1%
Change over 10 sessions
Bearish
ATR (14)
$1.50
Typical daily range, 21.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for RGNX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RGNX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow RGNX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for RGNXHow many large options trades hit RGNX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in RGNX in the last 90 days.
From SEC Form 4 filings by RGNX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RGNX is in one of them and how their past RGNX trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About REGENXBIO
REGENXBIO is a biotechnology company based in Rockville, Maryland, that develops gene therapies. Its treatments use modified viruses called AAV vectors, which are designed to deliver working genes into cells. The company's own pipeline targets eye, muscle and nervous system diseases. It also licenses its vector platform to drugmakers such as AbbVie and Novartis, which develop treatments for their own patients.